دورية أكاديمية
Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol.
العنوان: | Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol. |
---|---|
المؤلفون: | Driessen DAJJ; Department of Radiation Oncology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., de Gouw DJJM; Department of Surgery, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Stijns RCH; Department of Surgery, Radboud University Medical Center, 6525 Nijmegen, The Netherlands.; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Litjens G; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Israël B; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Philips BWJ; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Hermans JJ; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Dijkema T; Department of Radiation Oncology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Klarenbeek BR; Department of Surgery, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., van der Post RS; Department of Pathology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., van Engen-van Grunsven ACH; Department of Pathology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Brosens LAA; Department of Pathology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Veltien A; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Zámecnik P; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands., Scheenen TWJ; Department of Medical Imaging, Radboud University Medical Center, 6525 Nijmegen, The Netherlands. |
المصدر: | Methods and protocols [Methods Protoc] 2022 Mar 07; Vol. 5 (2). Date of Electronic Publication: 2022 Mar 07. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101720073 Publication Model: Electronic Cited Medium: Internet ISSN: 2409-9279 (Electronic) Linking ISSN: 24099279 NLM ISO Abbreviation: Methods Protoc Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2018]- |
مستخلص: | Background: In various cancer types, the first step towards extended metastatic disease is the presence of lymph node metastases. Imaging methods with sufficient diagnostic accuracy are required to personalize treatment. Lymph node metastases can be detected with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging (MRI), but this method needs validation. Here, a workflow is presented, which is designed to compare MRI-visible lymph nodes on a node-to-node basis with histopathology. Methods: In patients with prostate, rectal, periampullary, esophageal, and head-and-neck cancer, in vivo USPIO-enhanced MRI was performed to detect lymph nodes suspicious of harboring metastases. After lymphadenectomy, but before histopathological assessment, a 7 Tesla preclinical ex vivo MRI of the surgical specimen was performed, and in vivo MR images were radiologically matched to ex vivo MR images. Lymph nodes were annotated on the ex vivo MRI for an MR-guided pathological examination of the specimens. Results: Matching lymph nodes of ex vivo MRI to pathology was feasible in all cancer types. The annotated ex vivo MR images enabled a comparison between USPIO-enhanced in vivo MRI and histopathology, which allowed for analyses on a nodal, or at least on a nodal station, basis. Conclusions: A workflow was developed to validate in vivo USPIO-enhanced MRI with histopathology. Guiding the pathologist towards lymph nodes in the resection specimens during histopathological work-up allowed for the analysis at a nodal basis, or at least nodal station basis, of in vivo suspicious lymph nodes with corresponding histopathology, providing direct information for validation of in vivo USPIO-enhanced, MRI-detected lymph nodes. |
References: | J Magn Reson Imaging. 1997 Sep-Oct;7(5):774-83. (PMID: 9307901) Eur J Radiol. 2021 May;138:109636. (PMID: 33721766) Eur Urol. 2018 Sep;74(3):376-386. (PMID: 29908878) N Engl J Med. 2003 Jun 19;348(25):2491-9. (PMID: 12815134) Invest Radiol. 2019 Oct;54(10):645-652. (PMID: 31219996) Eur J Radiol. 2009 Jan;69(1):59-66. (PMID: 19112002) Lancet Oncol. 2008 Sep;9(9):850-6. (PMID: 18708295) Magn Reson Med. 2017 Sep;78(3):1020-1028. (PMID: 27714842) Radiology. 1990 May;175(2):489-93. (PMID: 2326474) Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2018 Jan;10(1):. (PMID: 28382713) J Thorac Cardiovasc Surg. 2006 Dec;132(6):1374-81. (PMID: 17140960) Eur Radiol. 2019 Dec;29(12):6529-6538. (PMID: 31201525) Magn Reson Imaging. 2020 Dec;74:258-265. (PMID: 32976957) J Nucl Med. 2021 Sep 1;62(9):1258-1263. (PMID: 33517328) Dig Dis. 2012;30 Suppl 2:2-8. (PMID: 23207926) Lancet. 1986 Jun 28;1(8496):1479-82. (PMID: 2425199) Eur J Radiol. 2011 Nov;80(2):582-9. (PMID: 20047813) Dis Colon Rectum. 2014 Jan;57(1):32-8. (PMID: 24316943) Invest Radiol. 2021 Jan;56(1):42-49. (PMID: 33156126) J Nucl Med. 2013 Aug;54(8):1171-4. (PMID: 23908265) Surg Clin North Am. 2013 Jun;93(3):647-62. (PMID: 23632150) Eur Urol. 2009 Apr;55(4):761-9. (PMID: 19144456) BMC Cancer. 2019 Jul 4;19(1):662. (PMID: 31272485) Eur Radiol. 2011 Feb;21(2):310-7. (PMID: 20694817) Front Oncol. 2021 Feb 05;10:637513. (PMID: 33634033) Eur J Cancer. 2013 Feb;49(3):616-24. (PMID: 23084842) |
فهرسة مساهمة: | Keywords: 7 Tesla; lymph node; magnetic resonance imaging; nodal staging; node-to-node correlation; pathology |
تواريخ الأحداث: | Date Created: 20220322 Latest Revision: 20220325 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC8938816 |
DOI: | 10.3390/mps5020024 |
PMID: | 35314661 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2409-9279 |
---|---|
DOI: | 10.3390/mps5020024 |